Bromobenzene

Bromobenzene

SCHEMBL704553

Brc1ccccc1.C1CCOOC1.c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
TDP1 Q9NUW8 1/20 0.58
MAPK1 P28482 1/20 0.42
ORAI1 Q96D31 3/20 0.41
ORAI2 Q96SN7 3/20 0.41
ORAI3 Q9BRQ5 3/20 0.41
TRPV6 Q9H1D0 3/20 0.41
CYP2A6 P11509 1/20 0.35
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
HTR2A P28223 1/20 0.32
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromobenzene SCHEMBL27149738 1.00 ALDH1A1 (0.58) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL3834436 0.95 ALDH1A1 (0.58) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL14795351 0.84 ALDH1A1 (0.58) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL6115841 0.84 ALDH1A1 (0.41) ALDH1A1TDP1MAPK1SMN1; SMN2CYP2C19
Bromobenzene SCHEMBL129999 0.82 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL28753154 0.80 ALDH1A1 (0.79) ALDH1A1TDP1MAPK1CYP2A6NPC1
Bromobenzene SCHEMBL1736835 0.80 ALDH1A1 (0.92) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL313507 0.80 ALDH1A1 (0.92) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL29116318 0.80 ALDH1A1 (0.92) ALDH1A1TDP1MAPK1ORAI1ORAI2
Bromobenzene SCHEMBL313505 0.80 ALDH1A1 (0.92) ALDH1A1TDP1MAPK1ORAI1ORAI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256378-A1 FLUORESCENT CELLULAR MARKERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-10-07 US claimed
EP-3091014-A1 FLUORESCENT CELLULAR MARKERS Zayas, Beatriz (US) 2016-11-09 EP disclosed
US-8124770-B2 Fluorescent cellular markers NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-28 US disclosed
US-20100256378-A1 FLUORESCENT CELLULAR MARKERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256378-A1 FLUORESCENT CELLULAR MARKERS AIFM1, CASP3, BAX ALDH1A1 3502/4885TDP1 1492/4885MAPK1 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.